Evidence map›Paper›PMID 28861423›Full record

ReviewAnnals of translational medicine2017

The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.

Demetrios Moris, Michael Spartalis, Eleftherios Spartalis, Georgia-Sofia Karachaliou, Georgios I Karaolanis, Gerasimos Tsourouflis, Diamantis I Tsilimigras, Eleni Tzatzaki, Stamatios Theocharis

Open access · hybridAbstract readReview
In one paragraph

Review in Annals of translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 3 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 3 syntheses or guidelines pooled it, 292 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. A highly penetrantbioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Contrasting the genetic architecture of cardiac glutathione against other organs: unveiling a unique tissue-specific locus.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Demetrios MorisDepartment of Surgery, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Michael SpartalisDivision of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece.
Eleftherios SpartalisLaboratory of Experimental Surgery and Surgical Research, Medical School, University of Athens, Athens, Greece.
Georgia-Sofia KarachaliouLaboratory of Experimental Surgery and Surgical Research, Medical School, University of Athens, Athens, Greece.
Georgios I KaraolanisDepartment of Vascular Surgery, Medical School, University of Athens, Athens, Greece.
Gerasimos TsourouflisLaboratory of Experimental Surgery and Surgical Research, Medical School, University of Athens, Athens, Greece.
Diamantis I TsilimigrasDepartment of Vascular Surgery, Medical School, University of Athens, Athens, Greece.
Eleni TzatzakiDivision of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece.
Stamatios TheocharisDepartment of Pathology, Medical School, University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GROnassis Cardiac Surgery Center · GRCenter for Vascular Biology Research · USThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute and chronic excessive intracellular increase of reactive oxygen species (ROS) is involved in the development and progression of cardiovascular diseases. ROS are by-products of various oxidative physiological and biochemical processes. Sources of ROS are mitochondrial respiration, NADH/NADPH oxidase, xanthine oxidoreductase or the uncoupling of nitric oxide synthase (NOS) in vascular cells. ROS mediate various signaling pathways that underlie cardiovascular pathophysiology. The delicate equilibrium between free-radical generation and antioxidant defense is altered in favor of the former, thus leading to redox imbalance, oxidative stress, and increased cellular injury. An understanding of the pathophysiological mechanisms mediated by oxidative stress is crucial to the prevention and treatment of cardiovascular diseases.

Indexed as

cardiovascularmyocardialoxidative stressReactive oxygen species (ROS)redox

Identifiers

PMID28861423
PMCPMC5566734
OpenAlexW2744282338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.